The 6th edition of the Phage Therapy Congress world conference on Targeting Phage Therapy is an in-person and online event, which will be held in Paris, France from Thursday 1st June till Friday 2nd June 2023.
What is the 6th Targeting Phage Therapy conference and Why attend?
Questions, Controversies, and What is Next? Strategies to bring phage therapy to another level
Targeting Phage Therapy 2023 will highlight the recent innovations and clinical applications of phages, validation and limitations. Targeting Phage Therapy 2023 will also cover how phages will transform the medicine of tomorrow. Phages will be the hottest topic not only to combat infection and antibiotic resistance, but also to modulate microbiota.
Countdown to Summit
Who will be at the 6th Targeting Phage Therapy conference?
Over 20 speakers and key global leaders from across the globe will be attending.
A discussion will be held on how to overcome barriers between experts, academics, industrials, and regulators.
Agenda for the 6th Targeting Phage Therapy 2023
Thursday 1st June 2023
Domenico Frezza from University of Roma Tor Vergata, Italy, and Marvin Edeas from INSERM – Institut Cochin, Université de Paris, France – General Introduction of Targeting Phage Therapy 2023
Martha Clokie from University of Leicester, United Kingdom – Challenges and Opportunities for Bacteriophage Therapy
Domenico Frezza from University of Roma Tor Vergata, Italy – Phage Therapy: Vision and Gaps
Mzia Kutateladze from Eliava Institute of Bacteriophage, Georgia – Phage Therapy: History in the Soviet Unions and Potential Treatment of Human Infections
William Summers from Yale University, USA – Historical Reflections of the Trials and Tribulations of Phage Therapy: 1930-1950
Lilian Musila from U.S. Army Medical Research Directorate, Kenya – Potential of Therapeutic Phages to Combat MDR ESKAPE Pathogens in Developing Nations
Jessica Sacher from Co-Founder of Phage Directory, Australia – Using Advanced Metrology Tools to Evaluate Phage Aggregation in Liquid Formulations
Jean-Paul Pirnay from Queen Astrid Military Hospital, Belgium – Bacteriophages: It’s a medicine, Jim, but not as we know it
Ryszard Międzybrodzki from Hirszfeld Institute of Immunology and Experimental Therapy PAS, Poland – Phages in the Medical Research Activity in Poland
Pranav Johri from Founder of Vitalis Phage Therapy, India – From Patient to Advocate – Introducing Phage Therapy to India
Tristan Ferry from Hospices Civils de Lyon, France – The Use of Bacteriophage Therapy for Complex Bacterial Infections: the PHAGEinLYON Experience
Jolien Onsea from KU Leuven, Belgium – The Use of Bacteriophage Therapy for Difficult-to-Treat Musculoskeletal Infections: the PHAGEFORCE Experience
Cara Fiore from Food and Drug Administration (FDA), USA – The Regulation of phage therapy applications in humans in the USA
Artem Kuzovlev from Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Russia – Adaptive Phagotherapy Algorhythms in Treatment and Prevention of Nosocomial Infections in Critically Ill Patients
Peter Kotsoana Montso from North-West University, South Africa – Comparative Genomics and Proteomics Analysis of Novel Phages Infecting Multi-drug Resistant Escherichia Coli O177 Strain
Friday 2nd June 2023
Noemi Poerio from University of Rome “Tor Vergata”, Italy – A Novel Combined Host- and Pathogen-Directed Therapeutic Approach to Fight Infections by MDR- Klebsiella pneumoniae
Farzaneh Moghtader from SET Medikal/NanoBMT, Turkey – Combined Therapies of Wound Infections with Phages/MSCs Aggregates
Mariagrazia Di Luca from University of Pisa, Italy – Phage-based drugs for the treatment of biofilm-associated infections
Anna Pistocchi from Università degli Studi di Milano, Italy – Investigating the Therapeutic Potential of Phages as Antibacterials and Immunomodulators in a
Zebrafish Model of Cystic Fibrosis
Alexander Sulakvelidze President and CEO of Intralytix, Inc., USA – Modern Approaches for Optimizing Therapeutic Phage Preparations
Aleksandra Petrovic Fabijan from Westmead Institute for Medical Research, Australia – Therapeutic Monitoring of Phage Therapy
David Jernigan from PhagenCorp, LLC, USA – Inducing Native Phages From the Human Virome to Address Targeted Infections
Anders S. Nilsson from Stockholm University, Sweden – Novel Computer Program for Modelling Bacteriophage Infection Kinetics
Rodrigo Ibarra Chavez from University of Copenhagen, Denmark – Phage-Inducible Chromosomal Islands Promote Genetic Variability by Blocking Phage Reproduction
TBC – Bacteriophages & Microbiota: On the Way to a Medical Revolution?
Ekaterina Chernevskaya from Federal Research and Clinical Center of Intensive Care Medicine and Rehabitology, Russia – Phage Therapy in Post-covid Rehabilitation
View past events by Phage Therapy Congress